MEMS Reagentless Biosensor

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$100,000.00
Award Year:
1997
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Award Id:
36901
Agency Tracking Number:
36901
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
401 Camp Craft Rd, Austin, TX, 78746
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Dr. Robert C. Chin
(512) 306-1100
Business Contact:
() -
Research Institute:
n/a
Abstract
One of the most serious obstacles to the practical implementation of biosensor technology for BW and CW detection onto UAV 5 and other remote deployment applications is the need for miniaturization of the sensor systems. To meet this need, Systems & Processes Engineering Corporation (SPEC) proposes to develop a miniaturized biosensor system which is essentially reagentless. The proposed system will use a novel fluorescence quenching strategy with no antibody separation steps or sophisticated multiple-fluid injection steps. The proposed system will be implemented into a MEM package which will include a telemetry system for remote deployment applications. The MEM package will include submodules for electronics, microfluidics, optics and air intake and sample preparation and will be designed to be less than 2"x2"x1" in size. The proposed antibody engineering for a fluorescence quenching immunoassay, will be done using novel mutagenesis and antibody expression methods recently developed by Drs. Iverson and Georgiou's. To implement the proposed fluorescence quenching immunoassay into a MEMS, SPEC has developed a teaming arrangement with the MEMS foundry at MCNC. The proposed microfluidic design will be developed by SPEC and MCNC design tool technology will be used to implement the micro-biosensor design in Phase II. The development of the fluorescence quenching immunoassay will provide a technology for clinical applications which is reagentless. The MEM biosensor system permits the developrnent of small, highly portable diagnostic systems. The use of Drs. Iverson and Georgiou's patented process for systematic optimization of antibody affinity by saturation mutagenesis will allow the development of high specificity, high affinity antibodies where none currently exist. These technologies, both in combination and individually have significant use in warfare, environmental, agricultural and medical applications.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government